Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure. Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, et al. Clin Gastroenterol Hepatol 2024 Mar 14:S1542-3565(24)00253.

Read + Share

Amedeo Smart

Independent Medical Education

Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, et al. Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure. Clin Gastroenterol Hepatol 2024 Mar 14:S1542-3565(24)00253.
PMID: 38492904